Medicare Enrolled
Dr. Waleed Bolad, MD
Rheumatology · Orlando, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bolad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bolad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bolad
Dr. Waleed Bolad is a rheumatology specialist in Orlando, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Bolad performed 80,770 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bolad received a total of $41,748 from 49 pharmaceutical and/or device companies across 1230 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bolad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 30% volume in FL
$41,748 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 120763 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗80,770
Medicare services
Top 30% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
52,000 | $4 | $11 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
15,898 | $10 | $26 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,475 | $34 | $83 |
| Denosumab injection (Prolia/Xgeva) | 2,520 | $18 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
571 | $95 | $270 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
371 | $93 | $345 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
305 | $51 | $189 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
116 | $100 | $191 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
101 | $21 | $110 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
80 | $60 | $259 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
64 | $11 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $121 | $415 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
56 | $76 | $237 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
42 | $9 | $40 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
32 | $1 | $2 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
29 | $4 | $60 |
| Injection, methylprednisolone acetate, 40 mg | 22 | $6 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
17 | $40 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $67 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
30.7% high complexity
68.5% medium
0.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$41,748
Total received (2018-2024)
Avg $5,964/year across 7 years
Top 14% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
1,230
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,795
2023
$9,376
2022
$12,234
2021
$2,553
2020
$5,318
2019
$3,538
2018
$2,933
Payments by company (2024)
Mallinckrodt Hospital Products Inc.
$1,217
ABBVIE INC.
$919
Janssen Biotech, Inc.
$449
GlaxoSmithKline, LLC.
$438
Amgen Inc.
$426
PFIZER INC.
$365
UCB, Inc.
$351
GENZYME CORPORATION
$285
AstraZeneca Pharmaceuticals LP
$237
Novartis Pharmaceuticals Corporation
$166
Lilly USA, LLC
$158
ANI Pharmaceuticals, Inc.
$147
Aurinia Pharma U.S., Inc.
$89
SOBI, INC
$79
Alexion Pharmaceuticals, Inc.
$71
E.R. Squibb & Sons, L.L.C.
$58
Fresenius Kabi USA, LLC
$47
Cardinal Health Inc
$43
Genentech USA, Inc.
$40
Organon Llc
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Sandoz Inc.
$29
Ultragenyx Pharmaceutical Inc.
$27
Kiniksa Pharmaceuticals International, plc
$25
Teva Pharmaceuticals USA, Inc.
$22
Fidia Pharma USA Inc.
$20
Radius Health, Inc.
$13
Top 3 companies account for 44.6% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$15,222
UCB, Inc.
$3,318
GENZYME CORPORATION
$2,869
Janssen Biotech, Inc.
$2,364
Amgen Inc.
$2,306
Horizon Therapeutics plc
$1,708
PFIZER INC.
$1,560
ABBVIE INC.
$1,390
Novartis Pharmaceuticals Corporation
$1,294
GlaxoSmithKline, LLC.
$1,175
AbbVie Inc.
$1,035
AbbVie, Inc.
$949
Lilly USA, LLC
$910
AstraZeneca Pharmaceuticals LP
$778
Aurinia Pharma U.S., Inc.
$738
Genentech USA, Inc.
$460
E.R. Squibb & Sons, L.L.C.
$340
Sobi, Inc
$319
ANI Pharmaceuticals, Inc.
$318
Celgene Corporation
$313
Mallinckrodt Enterprises LLC
$302
Janssen Pharmaceuticals, Inc
$294
Mallinckrodt LLC
$194
Boehringer Ingelheim Pharmaceuticals, Inc.
$177
SOBI, INC
$176
SANOFI-AVENTIS U.S. LLC
$145
Antares Pharma, Inc.
$123
Alexion Pharmaceuticals, Inc.
$114
Ferring Pharmaceuticals Inc.
$108
NeuroMetrix Inc
$99
Radius Health, Inc.
$81
Horizon Pharma plc
$65
DePuy Synthes Sales Inc.
$59
Sandoz Inc.
$54
Ultragenyx Pharmaceutical Inc.
$48
Fresenius Kabi USA, LLC
$47
Cardinal Health Inc
$43
Organon Llc
$40
Kyowa Kirin, Inc.
$27
Kiniksa Pharmaceuticals International, plc
$25
Teva Pharmaceuticals USA, Inc.
$22
Fidia Pharma USA Inc.
$20
Sebela Pharmaceuticals Inc.
$19
Hikma Pharmaceuticals USA
$19
Kiniksa Pharmaceuticals, Ltd.
$19
Boston Scientific Corporation
$19
Flexion Therapeutics, Inc.
$18
Mission Pharmacal Company
$13
MEDAC PHARMA, INC.
$13
Top 3 companies account for 51.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Aquoral · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · Crysvita · EUFLEXXA · EVENITY · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · HADLIMA · HUMIRA · HYM/HYN · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUCALA · OFEV · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Truxima · Tymlos · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
40
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
CENTRAL FLORIDA BEHAVIORAL HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bolad is a mixed practice specialist, with above-average Medicare volume (top 30% in FL), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bolad experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Bolad performed 52,000 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bolad receive payments from pharmaceutical companies?
Yes. Dr. Bolad received a total of $41,748 from 49 companies across 1,230 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bolad's costs compare to other rheumatologists in Orlando?
Dr. Bolad's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bolad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Orlando
Browse rheumatologists in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology